Melanoma is the most aggressive and potentially lethal form of skin cancer, originating in the melanocytes (pigment-producing cells) of the skin. While melanoma accounts for only about 1% of all skin cancer diagnoses, it is responsible for the vast majority of skin cancer deaths. The five-year survival rate exceeds 99% when detected at Stage 0 or Stage I, but drops dramatically to approximately 35% once the cancer metastasizes to distant organs. Early identification using the ABCDE clinical criteria and prompt dermatological biopsy is the single most critical factor in achieving a favorable outcome.
Discovering a new, dark, or irregularly shaped mole on the body triggers immediate, intense anxiety for most patients. Because the average adult has between 10 and 40 moles on their skin, determining which pigmented lesions are completely harmless and which require urgent clinical evaluation can feel overwhelming.
Melanoma does not always look like what patients expect. It can appear as a flat, barely raised patch of discoloration rather than a raised, protruding bump. It can also develop in anatomical locations that receive minimal direct sun exposure, catching patients completely off guard.
Learning the precise clinical criteria that dermatologists use to evaluate suspicious moles empowers patients to perform effective monthly self-examinations and seek rapid professional evaluation when a lesion displays warning characteristics.
The ABCDE Rule for Mole Evaluation#
Dermatologists use the ABCDE mnemonic as a standardized clinical framework for evaluating suspicious pigmented skin lesions. "A" stands for Asymmetry, where one half of the mole does not mirror the other half. "B" evaluates the Border, flagging moles with ragged, blurred, or notched edges.
"C" examines Color variation, identifying lesions containing multiple shades of brown, black, red, white, or blue within a single mole. "D" assesses Diameter, flagging any lesion larger than 6 millimeters (roughly the size of a pencil eraser). "E" tracks Evolution, identifying any mole that has recently changed in size, shape, color, or elevation over weeks or months.
Hidden Locations Where Melanoma Develops#
Patients commonly assume melanoma only develops on sun-exposed skin surfaces like the face, arms, and upper back. Clinical oncology data reveals that melanoma frequently appears in surprising anatomical locations that patients rarely inspect during routine self-examinations.
Acral lentiginous melanoma develops under the fingernails or toenails, presenting as a dark, vertical streak or band running the length of the nail plate. Melanoma also develops on the scalp (hidden beneath dense hair), between the toes, on the soles of the feet, and inside the mouth or on the genitals. These hidden locations account for a disproportionate number of late-stage diagnoses because patients simply never think to check them.
The Biopsy Process#
When a dermatologist identifies a clinically suspicious mole during examination, the standard diagnostic procedure is a skin biopsy. The most common technique is an excisional biopsy, where the clinician removes the entire visible lesion along with a small surrounding margin of healthy tissue under local anesthesia.
The excised tissue is sent to a dermatopathologist who examines the cellular architecture under high-powered microscopy to determine the Breslow thickness (the precise depth of melanoma invasion measured in millimeters). Breslow thickness is the single most important prognostic factor, as lesions thinner than 1.0 millimeter carry an excellent survival prognosis while those exceeding 4.0 millimeters indicate a high risk of systemic metastasis.
Monthly Self-Examination Protocol#
Clinical dermatology guidelines recommend performing a thorough, full-body skin self-examination once per month to detect new or changing lesions early. Patients should use a full-length mirror and a hand mirror together to systematically inspect all skin surfaces including the back, scalp, soles, and between fingers and toes.
Patients should photograph any moles they are monitoring to create a visual baseline for tracking changes over time. Any mole that satisfies two or more of the ABCDE criteria, bleeds spontaneously without trauma, itches persistently, or develops a crusty surface texture warrants an immediate appointment with a board-certified dermatologist for professional clinical evaluation and potential biopsy.
Track Complex Biomarkers Privately with Meridian
Manage your clinical lab results securely on your iPhone. 100% On-Device & Zero-Knowledge. Zero cloud servers. Zero data tracking.